When we investigated the involvement of five oncogenic pathways, including Wnt, TGF-β, p53, PI3K, and RTK/Ras signaling pathways, there was clearly no distinct difference between the CRCs with and without GIST. This evidence concerns the gene TGFB1 and gastrointestinal stromal tumor.